Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Rowland Yeo

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|April 4, 2025
Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactationXian Pan, Karen Rowland Yeo
Clinical Pharmacology and Therapeutics|April 20, 2023
Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding InfantsXian Pan, Karen Rowland Yeo
CPT: Pharmacometrics & Systems Pharmacology|February 25, 2023
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profileKaren Rowland Yeo, David Wesche
Journal of Cardiovascular Risk|October 24, 2002
Coronary risk versus cardiovascular risk for treatment decisions in mild hypertensionWilfred W Yeo, Karen Rowland Yeo
European Journal of Clinical Pharmacology|January 20, 2012
Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2David R Plowchalk, Karen Rowland Yeo
Journal of Hypertension|October 3, 2002
Should we treat high-normal blood pressure?Karen Rowland Yeo, Wilfred W Yeo
CPT: Pharmacometrics & Systems Pharmacology|January 11, 2020
Physiologically-Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and SamidorphanLei Sun, Lisa von Moltke, Karen Rowland Yeo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2016
How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology ApproachTrevor N Johnson, Masoud Jamei, Karen Rowland-Yeo
Expert Review of Clinical Pharmacology|March 12, 2013
Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approachKaren Rowland Yeo, Masoud Jamei, Amin Rostami-Hodjegan
Clinical Pharmacology and Therapeutics|November 13, 2025
Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction PredictionsKunal S Taskar, Pradeep Sharma, Karen Rowland Yeo
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Pharmacokinetics and Pharmacodynamics|April 4, 2025
Advancing inclusive healthcare through PBPK modelling: predicting the impact of CYP genotypes and enzyme ontogenies on infant exposures of venlafaxine and its active metabolite O-desmethylvenlafaxine in lactationXian Pan, Karen Rowland Yeo
Clinical Pharmacology and Therapeutics|April 20, 2023
Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding InfantsXian Pan, Karen Rowland Yeo
CPT: Pharmacometrics & Systems Pharmacology|February 25, 2023
PBPK modeling of ivermectin-Considerations for the purpose of developing alternative routes to optimize its safety profileKaren Rowland Yeo, David Wesche
Journal of Cardiovascular Risk|October 24, 2002
Coronary risk versus cardiovascular risk for treatment decisions in mild hypertensionWilfred W Yeo, Karen Rowland Yeo
European Journal of Clinical Pharmacology|January 20, 2012
Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2David R Plowchalk, Karen Rowland Yeo
Journal of Hypertension|October 3, 2002
Should we treat high-normal blood pressure?Karen Rowland Yeo, Wilfred W Yeo
CPT: Pharmacometrics & Systems Pharmacology|January 11, 2020
Physiologically-Based Pharmacokinetic Modeling for Predicting Drug Interactions of a Combination of Olanzapine and SamidorphanLei Sun, Lisa von Moltke, Karen Rowland Yeo
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2016
How Does In Vivo Biliary Elimination of Drugs Change with Age? Evidence from In Vitro and Clinical Data Using a Systems Pharmacology ApproachTrevor N Johnson, Masoud Jamei, Karen Rowland-Yeo
Expert Review of Clinical Pharmacology|March 12, 2013
Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approachKaren Rowland Yeo, Masoud Jamei, Amin Rostami-Hodjegan
Clinical Pharmacology and Therapeutics|November 13, 2025
Strategy for Identifying Rational Sensitivity Analysis Using PBPK Modeling for Precipitant Drug-Drug Interaction PredictionsKunal S Taskar, Pradeep Sharma, Karen Rowland Yeo
Pageof 6